SCHEMBL18634077

SCHEMBL18634077

CC(=O)C(OC(=O)N1CCN(S(=O)(=O)c2ccccc2C)CC1)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.42
▸ TSHR P16473 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ EPHX2 P34913 1/20 0.40
▸ F13A1 P00488 1/20 0.40
▸ TGM2 P21980 1/20 0.40
▸ TGM1 P22735 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MGLL Q99685 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15100855 0.87 MGLL (0.50) LMNAHSD17B10ALDH1A1TSHRSMN1; SMN2
SCHEMBL20408699 0.86 LMNA (0.46) LMNAHSD17B10ALDH1A1TSHRSMN1; SMN2
SCHEMBL18634273 0.85 MGLL (0.53) LMNAALDH1A1SMN1; SMN2GAAKMT2A
SCHEMBL18634071 0.82 KMT2A (0.52) LMNAALDH1A1SMN1; SMN2GAAHTT
SCHEMBL18634072 0.80 GPR183 (0.50) LMNASMN1; SMN2GAAKMT2AMEN1
SCHEMBL18634220 0.80 PKM (0.59) LMNAALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL18634274 0.78 SMN1; SMN2 (0.58) LMNASMN1; SMN2KDM4EGAAHTT
SCHEMBL15830167 0.76 ALDH1A1 (0.53) LMNAHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL20411236 0.76 PKM (0.47) SMN1; SMN2GAAMGLL
SCHEMBL18701958 0.74 EPHX2 (0.49) LMNAHSD17B10ALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2023-10-05 — — US disclosed
US-11530189-B2 Carbamate compounds and methods of making and using same H. LUNDBECKA/S (DK) 2022-12-20 — — US disclosed
US-20210188793-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME LUNDBECK LA JOLLA RESEARCH CENTER, INC. 2021-06-24 — — US disclosed
US-11021453-B2 Carbamate compounds and methods of making and using same LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2021-06-01 — — US disclosed
US-20200270223-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2020-08-27 — — US disclosed
EP-3698782-A1 CARBAMATE COMPOUNDS FOR USE IN THERAPY Lundbeck La Jolla Research Center, Inc. (US) 2020-08-26 — — EP disclosed
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2018-07-26 — — US disclosed
US-9957242-B2 Carbamate compounds and methods of making and using same THE SCRIPPS RESEARCH INSTITUTE (US) 2018-05-01 — — US disclosed
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530189-B2 Carbamate compounds and methods of making and using same ABHD6, ABHD16A, RABL6 LMNA 4184/4885HSD17B10 2149/4885ALDH1A1 2487/4885
US-11021453-B2 Carbamate compounds and methods of making and using same ABHD6, ABHD16A, RABL6 LMNA 4310/4885HSD17B10 2086/4885ALDH1A1 2385/4885
US-20210188793-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, RABL6 LMNA 4184/4885HSD17B10 2149/4885ALDH1A1 2487/4885
US-20200270223-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 LMNA 4712/4885HSD17B10 1408/4885ALDH1A1 1712/4885
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 LMNA 4712/4885HSD17B10 1408/4885ALDH1A1 1712/4885
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, RABL6 LMNA 4184/4885HSD17B10 2149/4885ALDH1A1 2487/4885
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 LMNA 4712/4885HSD17B10 1408/4885ALDH1A1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback